DIN 02388499 — ENALAPRILAT INJECTION USP 1.25 MG
ENALAPRILAT INJECTION USP is a solution of Enalaprilat marketed by HIKMA CANADA LIMITED. The full Enalaprilat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02388499
- Brand name
- ENALAPRILAT INJECTION USP
- Active ingredient
- Enalaprilat
- Strength
- 1.25 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HIKMA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Angiotensin-converting enzyme (ACE) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.